Apogee Therapeutics

1 follower

‌

Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.

Industries

Headquarters

San Francisco, United States

Employees

Links

Org chart

Michael Henderson

Chief Executive Officer at Apogee Therapeutics

Michael Henderson

Collapse

Carl Dambkowski

Chief Medical Officer

Senior Vice President, Business Development and Strategy

Senior Vice-President, Regulatory Affairs & Toxicology

Svp, Head Of People

Jane Pritchett Henderson

Chief Financial Officer

Wendy Aspden-Curran

Senior Vice President, Clinical Operations

Director, Regulatory Affairs

Mehrak Kiankarimi

Senior Vice President, Operations and Program Management

Senior Vice President, Quality Assurance

Senior Vice President, IT

Lukas Dillinger

Senior Vice President, Research & Translational Medicine

Rebecca Dabora, PhD

Chief Technical Officer

Chief Commercial Officer

Teams

Leadership Team

15 members

Clinical Operations and Development

5 members

People and Talent Team

4 members

Business and Strategy

3 members

Regulatory Affairs and Quality Assurance Team

3 members

Similar companies

Enko

4 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Tango Therapeutics

2 followers

Kyverna Therapeutics

6 followers

Ultima Genomics

3 followers

Cellares

2 followers

eGenesis

1 follower

BioXcellerator

1 follower

ACELYRIN

1 follower

Thermo Fisher Scientific

173 followers

Explore companies